-
Juve notch second straight win, Fiorentina's centenary party falls flat
-
US deports right-wing provocateur Milo Yiannopoulos
-
Rybakina eases injury fears ahead of US Open
-
Niger junta says it is back in control after soldiers' mutiny
-
Djokovic kicks off latest Grand Slam quest under US Open lights
-
Erasmus calls Rennie barbs over Springbok scrumming 'nonsense'
-
'Sorry' De Zerbi won't panic after Spurs shambles
-
Lawrence's fifty leaves Pakistan facing record chase to level England series
-
UN, Nepal warn of climate threat after deadly floods
-
Netanyahu condemns settler attack in flashpoint West Bank village
-
USTA boss says structure of new player council not yet set
-
Munoz saves Iraola in Liverpool draw, big-spending Spurs lose again
-
Tiny Elversberg stun Leverkusen on Bundesliga debut, Dortmund beat Hamburg
-
Newcastle condemn dismal Spurs to second successive defeat
-
Tambaram civic groups seek action on eight long-pending issues
-
Tamil Nadu goalball team’s national silver highlights need for wider support
-
Chennai councillors unite across parties to demand ward development funds
-
Tamil Nadu and NUS agree to expand postgraduate and research links
-
Court orders JIPMER assessment of Durai Dayanidhi before money-laundering trial
-
India and China have not named two new border meeting sites
-
French campaign sharpens as far right accuses left over civil disobedience calls
-
Kolkata police register new FIR against Mamata Banerjee over rally timing
-
About 50 Karnataka travellers return from Nepal as 24 remain missing
-
Andhra Pradesh Speaker seeks stronger sports quota and school facilities
-
Cyberabad civic body demolishes 19 unauthorised structures
-
Chembur man held over alleged poisoning of woman’s soft drink
-
Chinchpoklicha Chintamani begins 2026 arrival procession in Parel
-
BMC rejects negligence claims in three Rajawadi Hospital maternity cases
-
Ankle ligament tear ends Neeraj Chopra’s 2026 season
-
Dolly Parton’s Imagination Library leaves global children’s reading legacy
-
Thirty-seven Mumbai pilgrims return after Nepal flood disruption
-
Family searches for Boston engineer missing after Nepal-Tibet floods
-
Baladi Map app turns Lebanon’s local problems into a public record
-
Police appeal for footage after life-threatening Stratford assault
-
James Cleverly leaves shadow cabinet to seek London mayoralty
-
Rural Tamil Nadu students present 64 technology projects at IIT-M research park
-
Three Texas Tech softball players hurt in jet ski collision
-
Matt Leinart assesses Arch Manning and the leading names in college football
-
Felony assaults on older New Yorkers rise sharply, police data show
-
Los Angeles triplets weigh 19.3 pounds in unusually heavy birth
-
New finds strengthen case for Bethsaida at Sea of Galilee site
-
Editorial questions Letitia James’ record as New York attorney general
-
Five college football games that could shape the 2026 season
-
In London, son's agonising wait for news of parents missing in Nepal-Tibet floods
-
Norway's King Haakon VIII pays tribute to late father in first speech
-
Ivory Coast captain Kessie snubs Juventus to rejoin Atalanta
-
South Africa survive onslaught to beat New Zealand and level series
-
Strasbourg fight back to beat Lens in Ligue 1
-
Bryan Kohberger Seeks Judge’s Removal From Post-Conviction Case
-
Study Examines Why Women Have Consensual Sex Without Initial Desire
Musk's Neuralink says cleared for human test of brain implants
Elon Musk's start-up Neuralink on Thursday said it has gotten approval from US regulators to test its brain implants in people.
Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA."
Recruitment for a clinical trial is not yet open, according to Neuralink.
The aim of Neuralink implants is to enable human brains to communicate directly with computers, Musk said during a presentation by the start-up in December.
"We've been working hard to be ready for our first human (implant), and obviously we want to be extremely careful and certain that it will work well before putting a device in a human," he said at the time.
Musk -- who bought Twitter late last year and also owns SpaceX, Tesla and several other companies -- has been known to make ambitious predictions about his companies, with several such forecasts ultimately failing to pan out.
In July 2019, he vowed that Neuralink would be able to perform its first tests on humans in 2020.
Product prototypes, which are the size of a coin, have been implanted in the skulls of monkeys, demonstrations by the startup showed.
At the Neuralink presentation, the company showed several monkeys "playing" basic video games or moving a cursor on a screen through their Neuralink implant.
Musk said the company would try to use the implants to restore vision and mobility in humans who had lost such abilities.
"We would initially enable someone who has almost no ability to operate their muscles... and enable them to operate their phone faster than someone who has working hands," he said.
"As miraculous as it may sound, we are confident that it is possible to restore full body functionality to someone who has a severed spinal cord," he said.
Beyond the potential to treat neurological diseases, Musk's ultimate goal is to ensure that humans are not intellectually overwhelmed by artificial intelligence, he said.
Other companies working on similar systems include Synchron, which announced in July that it had implanted the first brain-machine interface in the United States.
Y.AlMasri--SF-PST